Article
[Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
Ugeskrift for laeger - 17 Mar 2014
Eskildsen Katrine Zwicky, Gätke Mona Ring
Abstract excerpt
The Danish Cholinesterase Research Unit (DCRU) is a nationwide unit for patients carrying mutations in the butyrylcholinesterase enzyme (BChE). BChE hydrolyzes the neuromuscular blocking drugs succinylcholine and mivacurium. Patients with mutations in the butyrylcholinesterase gene are at risk of experiencing a prolonged effect of the drugs, such as weakness or paralysis for hours. In order to diagnose the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
